S3F0 fundamentals
An in-depth look to SANTHERA PHARMA operating, investing, and financing activities
S3F0 free cash flow for H1 24 is -15.36 M CHF. For 2023, S3F0 free cash flow was 47.18 M CHF and operating cash flow was 47.27 M CHF.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CHF
TTM